MJardin Group Inc
MJardin Group, Inc., through its subsidiaries, cultivates, harvests, processes, and sells cannabis products in Canada and the United States. The company also provides consulting services, including strategic capital and financing, project management services for cultivation, licensure support, facility design, systems implementation, facility and equipment leasing, construction oversight, facilit… Read more
MJardin Group Inc (MJARF) - Net Assets
Latest net assets as of September 2021: $-122.24 Million USD
Based on the latest financial reports, MJardin Group Inc (MJARF) has net assets worth $-122.24 Million USD as of September 2021.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($85.95 Million) and total liabilities ($208.19 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-122.24 Million |
| % of Total Assets | -142.22% |
| Annual Growth Rate | N/A |
| 5-Year Change | -23324.75% |
| 10-Year Change | -39515.05% |
| Growth Volatility | 945.06 |
MJardin Group Inc - Net Assets Trend (2001–2020)
This chart illustrates how MJardin Group Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for MJardin Group Inc (2001–2020)
The table below shows the annual net assets of MJardin Group Inc from 2001 to 2020.
| Year | Net Assets | Change |
|---|---|---|
| 2020-12-31 | $-89.76 Million | -47.83% |
| 2019-12-31 | $-60.72 Million | -137.54% |
| 2018-12-31 | $161.75 Million | +904.94% |
| 2017-12-31 | $16.10 Million | +4064.51% |
| 2016-12-31 | $386.50K | -17.94% |
| 2015-12-31 | $470.99K | +223.38% |
| 2014-12-31 | $145.65K | +55.30% |
| 2013-12-31 | $93.79K | -38.42% |
| 2012-12-31 | $152.30K | -33.12% |
| 2011-12-31 | $227.74K | -23.92% |
| 2010-12-31 | $299.34K | +357.01% |
| 2009-12-31 | $65.50K | -48.25% |
| 2008-12-31 | $126.58K | -38.88% |
| 2007-12-31 | $207.09K | -25.34% |
| 2006-12-31 | $277.37K | +35.06% |
| 2005-12-31 | $205.37K | -27.71% |
| 2004-12-31 | $284.11K | -77.99% |
| 2003-12-31 | $1.29 Million | -8.68% |
| 2002-12-31 | $1.41 Million | -4.06% |
| 2001-12-31 | $1.47 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to MJardin Group Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 38163615300.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2020)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $263.49 Million | % |
| Other Comprehensive Income | $3.02 Million | % |
| Other Components | $31.18 Million | % |
| Total Equity | $-86.02 Million | 100.00% |
MJardin Group Inc Competitors by Market Cap
The table below lists competitors of MJardin Group Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
KAROON GAS AUST
BE:LBL
|
$8.33K |
|
Dawood Hercules Corporation Ltd
KAR:DAWH
|
$8.34K |
|
LIONTOWN
BE:LIS
|
$8.34K |
|
Creo Medical Group PLC
LSE:CREO
|
$8.34K |
|
BABLD
PINK:BABLD
|
$8.31K |
|
BELO SUN MNG (VE7.SG)
STU:VE7
|
$8.31K |
|
Pilot Gold Inc
STU:PGW
|
$8.30K |
|
GROWTHPOINT PPTYS
F:G5JA
|
$8.30K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in MJardin Group Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2019 to 2020, total equity changed from -56,986,530 to -86,017,229, a change of -29,030,699.
- Net loss of 34,840,534 reduced equity.
- New share issuances of 1,000,000 increased equity.
- Other comprehensive income increased equity by 1,703,393.
- Other factors increased equity by 3,106,442.
Equity Change Factors (2019 to 2020)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-34.84 Million | -40.5% |
| Share Issuances | $1.00 Million | +1.16% |
| Other Comprehensive Income | $1.70 Million | +1.98% |
| Other Changes | $3.11 Million | +3.61% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares MJardin Group Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2001-12-31 | $0.26 | $0.00 | x |
| 2002-12-31 | $0.25 | $0.00 | x |
| 2003-12-31 | $0.23 | $0.00 | x |
| 2004-12-31 | $0.05 | $0.00 | x |
| 2005-12-31 | $0.03 | $0.00 | x |
| 2006-12-31 | $0.04 | $0.00 | x |
| 2007-12-31 | $0.03 | $0.00 | x |
| 2008-12-31 | $0.02 | $0.00 | x |
| 2009-12-31 | $0.01 | $0.00 | x |
| 2010-12-31 | $0.05 | $0.00 | x |
| 2011-12-31 | $0.04 | $0.00 | x |
| 2012-12-31 | $0.02 | $0.00 | x |
| 2013-12-31 | $0.02 | $0.00 | x |
| 2014-12-31 | $0.02 | $0.00 | x |
| 2015-12-31 | $0.08 | $0.00 | x |
| 2016-12-31 | $0.06 | $0.00 | x |
| 2017-12-31 | $2.58 | $0.00 | x |
| 2018-12-31 | $4.05 | $0.00 | x |
| 2019-12-31 | $-0.70 | $0.00 | x |
| 2020-12-31 | $-0.97 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently MJardin Group Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -304.65%
- • Asset Turnover: 0.11x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-8.19%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2001 | -4.36% | 0.00% | 0.00x | 1.04x | $-211.54K |
| 2002 | -4.25% | -115.01% | 0.04x | 1.04x | $-201.44K |
| 2003 | -9.62% | -268.06% | 0.03x | 1.07x | $-253.32K |
| 2004 | 199.79% | 84.70% | 1.07x | 2.21x | $539.22K |
| 2005 | -45.36% | -1041.31% | 0.02x | 2.71x | $-113.70K |
| 2006 | 25.96% | 43.99% | 0.29x | 2.05x | $44.26K |
| 2007 | -33.94% | -379.11% | 0.03x | 2.59x | $-90.99K |
| 2008 | -63.61% | -498.42% | 0.04x | 3.62x | $-93.18K |
| 2009 | -93.24% | -721.15% | 0.02x | 5.91x | $-67.62K |
| 2010 | -21.48% | -3330.09% | 0.01x | 1.08x | $-94.24K |
| 2011 | -42.28% | -4449.72% | 0.01x | 1.11x | $-119.07K |
| 2012 | -49.53% | -4018.97% | 0.01x | 1.14x | $-90.67K |
| 2013 | -62.39% | -6908.74% | 0.01x | 1.21x | $-67.90K |
| 2014 | 35.61% | 59.60% | 0.34x | 1.75x | $37.30K |
| 2015 | 68.50% | 45.89% | 1.44x | 1.04x | $275.52K |
| 2016 | -21.86% | -2688.32% | 0.01x | 1.07x | $-123.14K |
| 2017 | 9.26% | 7.48% | 0.27x | 4.60x | $-119.24K |
| 2018 | -51.03% | -306.29% | 0.08x | 2.03x | $-100.76 Million |
| 2019 | 0.00% | -1001.87% | 0.16x | 0.00x | $-261.77 Million |
| 2020 | 0.00% | -304.65% | 0.11x | 0.00x | $-26.24 Million |
Industry Comparison
This section compares MJardin Group Inc's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $548,450,613
- Average return on equity (ROE) among peers: -450.37%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| MJardin Group Inc (MJARF) | $-122.24 Million | -4.36% | N/A | $8.31K |
| Ascend Wellness Holdings Inc (AAWH) | $142.87 Million | -33.75% | 5.44x | $48.90 Million |
| AB Science S.A (ABSCF) | $10.73 Million | -252.65% | 3.71x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $4.85K | -2005.32% | 0.49x | $603.58K |
| Aurora Cannabis Inc (ACB) | $2.04 Billion | -34.08% | 0.34x | $199.15 Million |
| Acreage Holdings Inc (ACRDF) | $204.27 Million | -30.85% | 1.41x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $7.90 Million | -63.15% | 1.15x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.51 Million | -44.22% | 0.06x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $2.07 Million | -2084.75% | 31.32x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $6.67 Million | 24.51% | 2.78x | $1.80 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.07 Billion | 20.55% | 0.55x | $85.61 Million |